|
Epidemiological study of unknown primary melanoma patients from the French national melanoma database RIC-Mel. |
|
|
No Relationships to Disclose |
|
|
|
Research Funding - Bristol-Myers Squibb (Inst) |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - Bristol-Myers Squibb; MSD; Novartis; Roche |
Consulting or Advisory Role - Bristol-Myers Squibb; Incyte; MSD; Novartis; Roche |
Research Funding - Bristol-Myers Squibb (Inst); MSD (Inst); Novartis (Inst); Roche (Inst) |
Expert Testimony - Bristol-Myers Squibb; MSD; Novartis; Roche |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Serono; MSD; Novartis (Inst); Roche |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - MSD |
Research Funding - MSD (Inst) |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Roche |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - Amgen; Bristol-Myers Squibb; MSD; Novartis; Roche |
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; MSD; Novartis; Roche |
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Novartis; Roche |
Research Funding - Bristol-Myers Squibb (Inst); Roche (Inst) |
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Roche |
|
|
No Relationships to Disclose |